Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Héctor Armando Alvarenga Andino"'
Autor:
Héctor M. Ramos-Zaldívar, Karla G. Reyes-Perdomo, Nelson A. Espinoza-Moreno, Ernesto Tomás Dox-Cruz, Thania Camila Aguirre Urbina, Astrid Yohaly Rivera Caballero, Eduardo Smelin Perdomo Dominguez, Sofía Guadalupe Peña Calix, Joselin Michelle Monterroso-Reyes, Erick Fernando Caballero Vásquez, Tarek Sai Zelaya Ortiz, Hilbron Eduardo Rodríguez-Machado, Marcelo Andres Forgas Solis, Iveth Sebilla Silva, Mauricio Edgardo Zavala Galeano, Alejandro Antonio Morga Alvarado, Angie María Nicolle Solís Medina, Leticia M. Guerrero-Díaz, Julia E. Jiménez-Faraj, Caroll Alejandra Perelló Santos, Wilberg A. Moncada Arita, Darwing Fabricio Valdiviezo Montufar, Josué David Hernández Sabillón, Mónica L. Sorto G., Xochilt Xiomara Padilla Navarro, Victoria A. Palomo-Bermúdez, Héctor Armando Alvarenga Andino, Sandra Patricia Reyes Guzman, María Haydee Rivera Reyes, Esdras Said Medina Paz, Joselyn Rosario Alvarado Enamorado, Yenny Mariel Sabillón Sagastume, Ariadna Stephanny Mejia Rivera, Claudia Michelle Posas Sarmiento, Xenia Vanessa Jiménez Pineda, Verónica Alejandra Hernández Puerto, Josué David Portillo Landaverde, Reyes S. Sergio, Ivin Perdomo R., Josué J. Rivera, Wendy Cecilia Mendoza Girón, Karla Melissa Tróchez Sabillón, Paola Nohemy Katsumata Leiva, Karla Elizabeth Pineda Toro, Jimena A. Montes-Gambarelli, Cristhiam Flores, Edison Salas-Huenuleo, Marcelo E. Andia
BackgroundCoronavirus disease 2019 (Covid-19) active cases continue to demand the development of safe and effective treatments. This is the first clinical trial to evaluate the safety and efficacy of oral thymic peptides.MethodsWe conducted a nonrand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29adc3c961405003f197706ecb8cb101
https://doi.org/10.1101/2021.12.05.21267318
https://doi.org/10.1101/2021.12.05.21267318
